Segall Bryant & Hamill’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-52,244
| Closed | -$8.01M | – | 843 |
|
|
2021
Q1 | $8.01M | Buy |
52,244
+18,691
| +56% | +$2.87M | 0.08% | 244 |
|
|
2020
Q4 | $4.21M | Sell |
33,553
-614
| -2% | -$77K | 0.05% | 319 |
|
|
2020
Q3 | $3.47M | Buy |
34,167
+24,803
| +265% | +$2.52M | 0.05% | 311 |
|
|
2020
Q2 | $911K | Buy |
9,364
+2,140
| +30% | +$208K | 0.02% | 460 |
|
|
2020
Q1 | $600K | Sell |
7,224
-807
| -10% | -$67K | 0.01% | 557 |
|
|
2019
Q4 | $893K | Sell |
8,031
-600
| -7% | -$66.7K | 0.01% | 542 |
|
|
2019
Q3 | $856K | Buy |
8,631
+36
| +0.4% | +$3.57K | 0.01% | 548 |
|
|
2019
Q2 | $852K | Buy |
8,595
+35
| +0.4% | +$3.47K | 0.01% | 557 |
|
|
2019
Q1 | $944K | Buy |
8,560
+229
| +3% | +$25.3K | 0.01% | 546 |
|
|
2018
Q4 | $766K | Sell |
8,331
-3,595
| -30% | -$331K | 0.01% | 567 |
|
|
2018
Q3 | $1.31M | Sell |
11,926
-8
| -0.1% | -$881 | 0.02% | 507 |
|
|
2018
Q2 | $1.11M | Buy |
+11,934
| New | +$1.11M | 0.02% | 519 |
|